CLSA has downgraded CreditAccess Grameen to underperform and set a target price of Rs 1,050, implying a downside of nearly 13% from the current market price of Rs 1,200.00.
The brokerage noted that the company reported a net profit of Rs 470 million in Q4, impacted by annualised credit costs of around 9%. It cited ongoing challenges in Karnataka, concerns around over-leveraging, and MFIN guardrails as factors contributing to an expected FY26 credit cost of 5.5%–6%.
Management has indicated that the stress could persist for another six months.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to consult certified financial professionals before making any investment decisions.
